Anti-tumour necrosis factor- treatment and weight gain in psoriasis: the "pudgy blanching' conundrum

被引：2
作者：
Puig, L. [1 ,2 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Dept Dermatol, Barcelona, Spain
[2] Univ Autonoma Barcelona, Barcelona 08025, Spain
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2013年 / 168卷 / 05期
关键词：
BODY-MASS INDEX; FACTOR-ALPHA TREATMENT; RHEUMATOID-ARTHRITIS; PLAQUE PSORIASIS; FACTOR THERAPY; INFLAMMATION; ADALIMUMAB; INFLIXIMAB; EFFICACY; CACHEXIA;
D O I：
10.1111/bjd.12284
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：923 / 924
页数：2
相关论文
共 22 条
  • [1] Impact of anti-tumour necrosis factor therapy on the weight of patients with rheumatoid arthritis
    Alcorn, Nicola
    Tierney, Ann
    Wu, Olivia
    Gilmour, Harper
    Madhok, Rajan
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (08) : 1571 - 1571
  • [2] Argiles Josep M., 2012, Critical Reviews in Oncogenesis, V17, P253
  • [3] Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment
    Briot, K
    Garnero, P
    Le Henanff, A
    Dougados, M
    Roux, C
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) : 1137 - 1140
  • [4] Briot K, 2008, J RHEUMATOL, V35, P855
  • [5] -174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers
    Di Renzo, Laura
    Bianchi, Alessia
    Saraceno, Rosita
    Calabrese, Vittorio
    Cornelius, Caroline
    Iacopino, Leonardo
    Chimenti, Sergio
    De Lorenzo, Antonino
    [J]. PHARMACOGENETICS AND GENOMICS, 2012, 22 (02) : 134 - 142
  • [6] Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment
    Di Renzo, Laura
    Saraceno, Rosita
    Schipani, Caterina
    Rizzo, Mariagiovanna
    Bianchi, Alessia
    Noce, Annalisa
    Esposito, Maria
    Tiberti, Sergio
    Chimenti, Sergio
    De Lorenzo, Antonino
    [J]. DERMATOLOGIC THERAPY, 2011, 24 (04) : 446 - 451
  • [7] INFLUENCE AND VARIATION OF THE BODY MASS INDEX IN PATIENTS TREATED WITH ETANERCEPT FOR PLAQUE-TYPE PSORIASIS
    Esposito, M.
    Mazzotta, A.
    Saraceno, R.
    Schipani, C.
    Chimenti, S.
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (01) : 219 - 225
  • [8] Body weight increment in patients treated with infliximab for plaque psoriasis
    Florin, V.
    Cottencin, A. C.
    Delaporte, E.
    Staumont-Salle, D.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (02) : E186 - E190
  • [9] Body-weight changes in psoriatic patients on systemic treatment
    Forien, M.
    Mahe, E.
    Sin, C.
    Marchal, A.
    Sigal, M. -L.
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2012, 139 (10): : 649 - 651
  • [10] Impact of infliximab on serum leptin levels in patients with Crohn's disease
    Franchimont, D
    Roland, S
    Gustot, T
    Quertinmont, E
    Toubouti, Y
    Gervy, MC
    Deviere, J
    Van Gossum, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (06) : 3510 - 3516
123